Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Stake in China Pharma R&D Center Co. Up for Sale

publication date: Nov 26, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
According to reports, a 24% stake in China Pharmaceutical R&D Center Co. is up for sale at a price of 15.4 million RMB ($2.5 million). The company is an R&D, technology and service platform under the state-owned China Resources Pharmaceutical Group Limited. The company reported declining revenues and a net loss for the first nine months of 2012. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors